Rest-Of-Europe Dental Soft-Tissue Regeneration Market Size, Share,Trends, Growth Analysis Report, 2029

Name: Rest-Of-Europe Dental Soft-Tissue Regeneration Market Size, Share,Trends, Growth Analysis Report, 2029
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Rest Of Europe Dental Soft-Tissue Regeneration Market analysis

Part of: Dental Soft-Tissue Regeneration Market (Global)

The Rest Of Europe Dental Soft-Tissue Regeneration Market was valued at $7.6 Million in 2024 and projected to reach to $10.8 Million by 2029, representing a compound annual growth rate of 7.3%. Rest Of Europe's dental soft-tissue regeneration market is positioned for steady expansion through 2029, driven by rising healthcare investments in periodontal care and increasing patient awareness of advanced treatment alternatives.

Rest Of Europe Dental Soft-Tissue Regeneration Market (2024-2029) : Size and Share

CAGR of

USD Million

Rest Of Europe Dental Soft-Tissue Regeneration Market Trends and Insights

Rest Of Europe represents a developing segment within the broader European dental regeneration landscape, driven by increasing adoption of advanced periodontal therapies and growing awareness of minimally invasive treatment options.
Rest Of Europe's market growth is supported by rising dental healthcare expenditure and improving access to regenerative dental procedures across secondary and tertiary care centers. Rest Of Europe is witnessing accelerating demand for soft-tissue grafting materials, guided tissue regeneration products, and biologics-based solutions.
Rest Of Europe's 7.3% compound annual growth rate reflects the region's gradual shift toward preventive and restorative dental care.
Rest Of Europe's market trajectory from 2024 to 2029 indicates strengthening healthcare infrastructure and increasing patient preference for tissue-preserving dental interventions over traditional extraction-based approaches..

Key Market Statistics

CAGR (2024-2029) 7.3% CAGR
Market Size, 2024 ~USD 7.6 Million
Forecast, 2029 ~USD 10.8 Million
Country Rest Of Europe

Rest Of Europe Dental Soft-Tissue Regeneration Market Overview

Market Valuation :

Rest Of Europe dental soft-tissue regeneration market valued at USD 7.6 million in 2024, demonstrating significant growth potential in this developing regional segment.

Projected Growth Trajectory :

Market expected to reach USD 10.8 million by 2029, representing a robust 7.3% CAGR, outpacing broader European adoption rates in periodontal regeneration therapies.

Therapeutic Adoption Drivers :

Increasing adoption of advanced periodontal therapies and minimally invasive treatment options are accelerating market penetration across Rest Of Europe healthcare systems.

Regional Market Positioning :

Rest Of Europe represents a developing but strategically important segment within the broader European dental regeneration landscape with emerging clinical adoption patterns.

Rest Of Europe Dental Soft-Tissue Regeneration Market Dynamics

The region's growing adoption of minimally invasive procedures reflects broader European trends toward precision dentistry and improved clinical outcomes. Key growth catalysts include expanding dental infrastructure, rising disposable incomes, and greater accessibility to regenerative technologies across Rest Of Europe markets.
As clinical evidence strengthens and reimbursement pathways improve, the market is expected to attract increased investment from both established and emerging dental regeneration companies seeking to establish regional footholds..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
JOHNSON & JOHNSON

Key Takeaways

Rest Of Europe's dental soft-tissue regeneration market is valued at USD 7.6 million in 2024 and will reach USD 10.8 million by 2029, representing a 7.3% CAGR.
Rest Of Europe is experiencing increased adoption of guided tissue regeneration and soft-tissue grafting procedures driven by rising periodontal disease prevalence.
Rest Of Europe's market growth is supported by improving reimbursement policies and expanding dental healthcare infrastructure across the region.
Rest Of Europe shows strong potential for biologics-based regenerative solutions as patient awareness and clinical acceptance continue to rise through 2029.

Dental Soft-Tissue Regeneration Market Report Scope

Report Metric	Details
Base Year	2024
Fastest Growing Segment	PERIODONTOLOGY (Application)
Forecast Period	2024�2029
Growth Rate	CAGR of 7.8% from 2024 to 2029
Largest Segment	AUTOGRAFTS (Product Type)
Market Size Base Year (Billions)	~USD 0.34 (2024)
Revenue Forecast (Billions)	~USD 0.54 (2029)
Segments Covered	Product Type, Application, End User

Rest Of Europe Dental Soft-Tissue Regeneration Market Report Segmentation

3 segment dimensions are covered across the global market.

By Product Type

Autografts
Collagen-Based Membranes
Other Products
Synthetic Biomaterials

By Application

Implantology
Other Applications
Periodontology

By End User

Academic & Research Institutes
Dental Hospitals
Dsos & Independent Clinics

Target Audience

Dental Device Manufacturers : Require Rest Of Europe-specific market sizing and growth forecasts to prioritize regional product launches, allocate R&D resources, and establish distribution partnerships in this developing market.
Healthcare Investment Firms : Need detailed Rest Of Europe market analysis to evaluate investment opportunities in dental regeneration companies, assess regional market maturity, and identify acquisition targets.
Dental Practice Networks & Clinics : Seek Rest Of Europe adoption trends and competitive intelligence to inform procurement decisions, clinical protocol development, and patient communication strategies for regenerative therapies.
Pharmaceutical & Biotech Companies : Require Rest Of Europe market insights to guide product development priorities, regulatory strategy, and commercialization timelines for soft-tissue regeneration therapeutics.
Healthcare Consultants & Analysts : Need comprehensive Rest Of Europe market data to support client advisory work, competitive benchmarking, and strategic recommendations in the dental regeneration sector.

Key Companies in the Rest Of Europe Dental Soft-Tissue Regeneration Market

Company	HQ	Ownership	Strongest segments
HENRY SCHEIN, INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ENVISTA	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ZIMVIE INC.	United States	Private Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
DENTSPLY SIRONA INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ABBVIE INC.	United States	Public Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
ADVANCED MEDICAL SOLUTIONS GROUP PLC	United Kingdom	Public Company	Collagen-based Membranes,Synthetic Biomaterials,Autografts,
TISSUE REGENIX	United Kingdom	Private Company	Autografts,Synthetic Biomaterials,Collagen-based Membranes,
MECCELLIS BIOTECH	France		Collagen-based Membranes,Synthetic Biomaterials,Autografts,

HENRY SCHEIN, INC.

Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.

ENVISTA

Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.

ZIMVIE INC.

Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.

DENTSPLY SIRONA INC.

Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.

ABBVIE INC.

AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.

ADVANCED MEDICAL SOLUTIONS GROUP PLC

Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.

TISSUE REGENIX

Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.

MECCELLIS BIOTECH

Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.

Reasons to Buy this Report

Regional Market Sizing & Forecasting : Obtain precise market valuation data specific to Rest Of Europe (USD 7.6M in 2024, USD 10.8M by 2029) with detailed CAGR analysis to support regional business planning and investment decisions.
Competitive Landscape Intelligence : Understand Rest Of Europe-specific competitive dynamics, market entry barriers, and positioning strategies for dental soft-tissue regeneration products in this developing regional segment.
Growth Driver Analysis : Identify key adoption catalysts unique to Rest Of Europe including therapeutic awareness trends, healthcare infrastructure development, and minimally invasive treatment penetration patterns.
Strategic Market Expansion Planning : Leverage Rest Of Europe-focused insights to develop targeted go-to-market strategies, partnership opportunities, and regional commercialization roadmaps for dental regeneration solutions.
Investment & Funding Decisions : Access comprehensive Rest Of Europe market data to evaluate investment potential, identify high-growth opportunities, and benchmark performance against regional growth trajectories.

Frequently asked questions

What is the current market size of dental soft-tissue regeneration in Rest Of Europe?

Rest Of Europe's dental soft-tissue regeneration market was valued at USD 7.6 million in 2024 and is expected to grow to USD 10.8 million by 2029.

What is the projected growth rate for Rest Of Europe's dental soft-tissue regeneration market?

Rest Of Europe's market is projected to grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2029.

What are the primary drivers of growth in Rest Of Europe's dental soft-tissue regeneration market?

Rest Of Europe's market growth is driven by increasing periodontal disease prevalence, rising adoption of minimally invasive procedures, improving reimbursement policies, and expanding dental healthcare infrastructure.

Which product types are most in demand in Rest Of Europe's dental soft-tissue regeneration market?

Rest Of Europe shows strong demand for guided tissue regeneration products, soft-tissue grafting materials, and biologics-based regenerative solutions.

How does Rest Of Europe's market growth compare to global trends?

Rest Of Europe's 7.3% CAGR is slightly below the global average of 7.8%, reflecting the region's developing market status within the broader European dental regeneration landscape.

RESEARCH METHODOLOGY

This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.

Secondary Research

The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.

Primary Research

In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.

A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:

Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:

List of major players operating in the products market at the regional and/or country level
Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
Summation of the market value of all segments/subsegments to arrive at the global diagnostics market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom-up Approach & Top-down Approach)

Data Triangulation

After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

Market Definition

Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.

Stakeholders

Dental soft-tissue regenerative material manufacturing companies
Distributors and suppliers of dental soft-tissue regeneration products
Medical device companies
Research and consulting firms
Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
Research institutes and academic centers
Contract research organizations (CROs)
Government associations
Venture capitalists and investors

Report Objectives

To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
To analyze the generative AI impact on the dental soft-tissue regeneration market

Get the Full Dental Soft-Tissue Regeneration Market Report

Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)